Triple-negative breast cancer which accounts for 15% of breast cancer cases is defined as lacking expression of estrogen receptor, progesterone receptor and human epidermal growth factor receptor type 2 (HER2) [2]. This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.